Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of lewis rats with myelin basic protein
- 28 February 1995
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 131 (2), 221-228
- https://doi.org/10.1016/0014-4886(95)90044-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- T Cell Lymphokine-Induced Secretion of Cytokines by Monocytes from Patients with Multiple SclerosisCellular Immunology, 1993
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991
- Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding ProteinDNA and Cell Biology, 1990
- An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.The Journal of Experimental Medicine, 1990
- T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosisNature, 1990
- T Cells Responsive to Myelin Basic Protein in Patients with Multiple SclerosisScience, 1990
- Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 1988
- Does cyclosporine act in vivo as it does in vitro?Immunology Today, 1986
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- The influence of cyclosporin A on the development of actively induced and passively transferred experimental allergic encephalomyelitisCellular Immunology, 1983